MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$868,684
Free Cash flow
-$845,749
Unit: Dollar
Positive Cash Flow Breakdown
Inventory
Accounts receivable
Amortization of intangible asset...
Others
Negative Cash Flow Breakdown
Reserve for inventory
Net loss
Deferred revenue
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-576,852
-205,037
-4,289,156
-964,849
Allowance for credit losses
-
-
-250,000
-
Depreciation
18,231
14,716
19,444
21,266
Amortization of debt discount
-
-
261,833
-
Amortization of intangible assets
55,888
56,039
56,206
56,329
Amortization of capitalized contract costs
38,185
40,000
38,848
42,448
Amortization of note payable
20,833
-159,167
-
60,000
Interest payable on note
27,000
27,000
-14,573
12,680
Loss on foreign currency
-
-
0
-
Reserve for inventory
-703,050
-98,970
-513,400
0
Impairment of investment
-
-
2,500,000
-
Operating leases right-of-use assets
12,304
-12,369
-
18,939
Share and warrant-based compensation for employees and consultants
42,652
40,744
40,586
31,660
Stock based directors fees
0
0
0
0
Bad debt expense
-
-
-15,000
-
Deferred income tax benefit
-
-
16,500
-
Amortization of operating lease right-of-use assets
-
-
12,876
-
Bad debts
0
-15,000
-
0
Accounts receivable
-67,572
352,632
261,318
-24,030
Allowance for credit losses
24,373
-
-
0
Due from factor
0
0
0
-154,769
Capitalized contract costs
10,280
22,824
14,562
11,200
Deposits
-
-
0
-
Right of use asset
-
-
0
-
Inventory
-665,707
-131,452
-536,697
75,638
Resalable software license rights
-
-
-
0
Prepaid expenses and other
-5,957
74,720
-101,052
49,330
Accounts payable
-98,227
2,074
-148,620
-233,331
Income tax payable
-
-
0
-
Accrued liabilities
42,648
-206,831
119,553
43,488
Deferred revenue
-211,605
265,404
-99,676
-235,350
Operating lease liabilities
-17,085
-1,819
-6,495
-6,132
Net cash used in operating activities
-845,749
-358,001
-1,830,601
-1,122,764
Capital expenditures
0
0
4,639
1,325
Costs incurred for issuance of common stock
-
-
462,994
-
Net cash provided by (used in) investing activities
0
0
-4,639
-1,325
Proceeds from note payable
0
-
0
1,000,000
Offering costs
0
-248,783
-
0
Proceeds for exercise of warrants
0
0
3,153,501
0
Repayment of note payable
-
-
455,000
-
Receipt of cash from employee stock purchase plan
7,660
-
9,200
0
Repayment of government loan
0
-38,179
-37,256
-37,492
Net cash provided by (used in) financing activities
7,660
-38,179
2,456,234
962,508
Effect of exchange rate changes
-30,595
-50,499
33,816
-73,911
Net increase (decrease) in cash and cash equivalents
-868,684
-446,679
654,810
-235,492
Cash and cash equivalents, beginning of period
2,247,984
2,694,663
2,039,853
437,604
Cash and cash equivalents, end of period
1,379,300
2,247,984
2,694,663
2,039,853
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Receipt of cash from
employee stock purchase...
$7,660
(774.43%↑ Y/Y)
Net cash provided by
(used in) financing...
$7,660
(-99.78%↓ Y/Y)
Net increase
(decrease) in cash and cash...
-$868,684
(-147.27%↓ Y/Y)
Canceled cashflow
$7,660
Inventory
-$665,707
(-1013.80%↓ Y/Y)
Accounts receivable
-$67,572
(-541.50%↓ Y/Y)
Amortization of intangible
assets
$55,888
(-63.88%↓ Y/Y)
Share and
warrant-based compensation...
$42,652
(-42.61%↓ Y/Y)
Accrued liabilities
$42,648
(139.55%↑ Y/Y)
Amortization of capitalized
contract costs
$38,185
(-58.39%↓ Y/Y)
Interest payable on note
$27,000
(-55.13%↓ Y/Y)
Allowance for credit
losses
$24,373
(109.75%↑ Y/Y)
Amortization of note payable
$20,833
(-82.64%↓ Y/Y)
Depreciation
$18,231
(-58.33%↓ Y/Y)
Operating leases
right-of-use assets
$12,304
(-1.91%↓ Y/Y)
Prepaid expenses and
other
-$5,957
(-124.42%↓ Y/Y)
Net cash used in
operating activities
-$845,749
(50.69%↑ Y/Y)
Effect of exchange rate
changes
-$30,595
(-146.63%↓ Y/Y)
Canceled cashflow
$1,021,350
Reserve for inventory
-$703,050
Net loss
-$576,852
(69.70%↑ Y/Y)
something is missing
-$250,000
Deferred revenue
-$211,605
(-34284.98%↓ Y/Y)
Accounts payable
-$98,227
(-237.72%↓ Y/Y)
Operating lease
liabilities
-$17,085
(-119.52%↓ Y/Y)
Capitalized contract costs
$10,280
(-79.22%↓ Y/Y)
Buy us a coffee
BIO KEY INTERNATIONAL INC (BKYI)
BIO KEY INTERNATIONAL INC (BKYI)